About

Who we are

We are an interdisciplinary, STEM-focused team supported by experienced leaders, world-class advisors, and top-notch investors.

Overview

60
+
Employees
$
100
M+
Funding
12
Investors
10
+
Therapeutics under development

Who we are

Interdisciplinary and
STEM-focused workforce

Drug Development

  • Antibody Discovery and Engineering
  • FROM TARGET TO CLINIC
  • RESEARCH COLLABORATIONS AND DRUG DEVELOPMENT PARTNERSHIP
Technology

  • Machine Learning
  • Software Engineering
  • Automation
Biology

  • Synthetic Biology
  • Genetics
  • Molecular Biology

Meet the team

We are a team of scientists, seasoned engineers, and problem solvers designing safer, more effective antibody therapies.

Investors

World-class investors

Awards & Recognition

Global recognition & industry awards

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed laoreet sapien ex, vel gravida nibh ornare quis. Cras fringilla magna a turpis accumsan ornare. Phasellus justo felis, egestas ut felis vel, posuere posuere nisi. Maecenas ut efficitur tellus,.

PARTNER

Partner with us

BigHat engages with strategic partners to tackle complex protein therapeutic design challenges.